Search results
Results from the WOW.Com Content Network
Myasthenia gravis affects 50 to 200 people per million. [3] [4] It is newly diagnosed in 3 to 30 people per million each year. [13] Diagnosis has become more common due to increased awareness. [13] Myasthenia gravis most commonly occurs in women under the age of 40 and in men over the age of 60. [1] [5] [14] It is uncommon in children. [1]
Myasthenia gravis, or MG, is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue. ... Some such environmental triggers could include infections, chronic stress, or ...
Pyridostigmine is a medication used to treat myasthenia gravis [1] and underactive bladder. [2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. [3] It is also used off-label to treat some forms of Postural orthostatic tachycardia syndrome.
Aminoglycosides can exacerbate weakness in patients with myasthenia gravis, and use is therefore avoided in these patients. [26] Aminoglycosides are contraindicated in patients with mitochondrial diseases as they may result in impaired mtDNA translation, which can lead to irreversible hearing loss, tinnitus, cardiac toxicity, and renal toxicity.
ChEIs may be used as drugs for Alzheimer's and myasthenia gravis, and also as chemical weapons and insecticides. [ 4 ] [ 5 ] Side effects when used as drugs may include loss of appetite , nausea , vomiting , loose stools , vivid dreams at night, dehydration , rash , bradycardia , peptic ulcer disease , seizures , weight loss , rhinorrhea ...
Neostigmine, sold under the brand name Bloxiverz, among others, is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. [3] [4] It is also used in anaesthesia to end the effects of non-depolarising neuromuscular blocking medication. [3]
To treat myasthenia gravis, where they are used to increase neuromuscular transmission. To treat glaucoma; To treat postural orthostatic tachycardia syndrome; As an antidote to anticholinergic poisoning; To reverse the effect of non-depolarising muscle relaxants; To treat neuropsychiatric symptoms of diseases such as Alzheimer's disease ...
Efgartigimod alfa, sold under the brand name Vyvgart, is a medication used to treat myasthenia gravis. [3] [4] Efgartigimod alfa is a neonatal Fc receptor blocker and is a new class of medication. [4] It is an antibody fragment that binds to the neonatal Fc receptor (FcRn), preventing FcRn from recycling immunoglobulin G (IgG) back into the ...